Literature DB >> 21372021

Pattern electroretinogram in glaucoma suspects: new findings from a longitudinal study.

Sebastian F N Bode1, Thomas Jehle, Michael Bach.   

Abstract

PURPOSE: Early detection of glaucoma remains a challenging problem and needs long-term, prospective studies. The pattern electroretinogram (PERG) directly reflects retinal ganglion cell function. The PERG was evaluated by extending a prospective study of patients with ocular hypertension and evaluated amplitude, PERG ratio, peak time, and trends thereof.
METHODS: One hundred twenty eyes of 64 patients with intraocular pressure greater than 25 mm Hg (or ≥ 23 mm Hg with additional risk factors), normal visual fields, normal optic disc appearance, and visual acuity ≥ 0.8 were included in the study. Mean follow-up time was 10.3 years. The per-visit measures of amplitude at 15 reversals/s to 0.8° check size, PERG ratio (0.8°/16°), peak time, visual field, and their trends were analyzed.
RESULTS: Over the course of the study 13 eyes converted to glaucoma according to a visual field definition. Amplitude to 0.8° check size, PERG ratio, and peak time were significantly lower in converters. Amplitude and PERG ratio predicted conversion 4 years ahead with a sensitivity/specificity of 67%/64% and 75%/76%, respectively. At this time, the ROC area was already significantly above chance for the PERG ratio. Comparison of the trends of converters and nonconverters revealed significant differences in the PERG ratio; however, trends did not predict conversion as successfully as single-visit measures.
CONCLUSIONS: The PERG, especially the PERG ratio, detected glaucoma patients 4 years before visual field changes occurred, with a sensitivity/specificity of 75%/76%. Slope analysis required multiple visits, but provided little additional information in detecting converters.

Entities:  

Mesh:

Year:  2011        PMID: 21372021     DOI: 10.1167/iovs.10-6381

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  30 in total

1.  Pattern electroretinogram progression in glaucoma suspects.

Authors:  Lori M Ventura; Iuri Golubev; William J Feuer; Vittorio Porciatti
Journal:  J Glaucoma       Date:  2013-03       Impact factor: 2.503

2.  [Electrophysiological examination methods in glaucoma diagnostics].

Authors:  C M Poloschek; M Bach
Journal:  Ophthalmologe       Date:  2012-04       Impact factor: 1.059

3.  Pattern electroretinogram to detect glaucoma: comparing the PERGLA and the PERG Ratio protocols.

Authors:  Michael Bach; Anke Ramharter-Sereinig
Journal:  Doc Ophthalmol       Date:  2013-10-15       Impact factor: 2.379

4.  Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma.

Authors:  Vincenzo Parisi; Marco Centofanti; Lucia Ziccardi; Lucia Tanga; Manuele Michelessi; Gloria Roberti; Gianluca Manni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-26       Impact factor: 3.117

5.  TGF-β signaling is required for maintenance of retinal ganglion cell differentiation and survival.

Authors:  T E Walshe; L L Leach; P A D'Amore
Journal:  Neuroscience       Date:  2011-05-27       Impact factor: 3.590

Review 6.  Electroretinography in glaucoma diagnosis.

Authors:  Laura J Wilsey; Brad Fortune
Journal:  Curr Opin Ophthalmol       Date:  2016-03       Impact factor: 3.761

7.  Comparing three different modes of electroretinography in experimental glaucoma: diagnostic performance and correlation to structure.

Authors:  Laura Wilsey; Sowjanya Gowrisankaran; Grant Cull; Christy Hardin; Claude F Burgoyne; Brad Fortune
Journal:  Doc Ophthalmol       Date:  2017-02-27       Impact factor: 2.379

8.  Ganglion cell loss in early glaucoma, as assessed by photopic negative response, pattern electroretinogram, and spectral-domain optical coherence tomography.

Authors:  Barbara Cvenkel; Maja Sustar; Darko Perovšek
Journal:  Doc Ophthalmol       Date:  2017-05-31       Impact factor: 2.379

9.  Pattern ERG and RNFL thickness in hypertensive eyes with normal blue-yellow visual field.

Authors:  Maurizio G Uva; Massimo Di Pietro; Antonio Longo; Katia Lauretta; Michele Reibaldi; Alfredo Reibaldi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-08-12       Impact factor: 3.117

10.  Long-term PERG monitoring of untreated and treated glaucoma suspects.

Authors:  Phillip S Gordon; Maja Kostic; Pedro F Monsalve; Giacinto Triolo; Luri Golubev; Gabriel Luna; Lori M Ventura; William J Feuer; Vittorio Porciatti
Journal:  Doc Ophthalmol       Date:  2020-03-09       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.